ClinicalTrials.gg
Not yet recruitingNCT07913191Updated Nov 3, 2026

Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia

An interventional study of Nurse - Directed Side - Lying Positioning and Nurse - Directed Semi-fowler's positioning in Pediatric Pneumonia, sponsored by University of Baghdad. Not yet recruiting. Open to participants aged 3 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of Baghdad · Not applicable, Interventional, and Supportive care

Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Non-randomized
Ages
3 Years to 5 Years
Sex
All
01

Study summary

Pneumonia is a common respiratory infection in children that may cause respiratory distress and impaired oxygenation. This quasi-experimental study aims to evaluate the effectiveness of nurse-directed therapeutic positioning on vital signs, oxygen saturation, and respiratory distress severity among children aged 3-5 years diagnosed with pneumonia. The study will compare two therapeutic positioning interventions, side-lying position and semi-Fowler's position, with a control group receiving routine nursing care. The outcomes will be assessed to determine the effects of these positioning interventions on the respiratory status of children with pneumonia.

02

Conditions studied

  • Pediatric Pneumonia

Keywords

  • Pneumonia
  • Children
  • Therapeutic Positioning
  • Side - Lying position
  • Semi - fowler's position
  • Oxygen Saturation
  • Respiratory Distress
  • Vital Signs
  • Pediatric Nursing
03

In context

Pneumonia

2,076 studies on the registry are indexed under Pneumonia; 288 are open to participants now.

This study's planned enrollment of 150 is above the median of 107 across 1,267 interventional studies indexed under Pneumonia.

Browse Pneumonia studies →

Lead sponsor

University of Baghdad is the lead sponsor of 169 studies on the registry; 68 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Children aged 3-5 years.
  2. Children diagnosed with pneumonia.
  3. Children admitted to the selected pediatric hospitals.
  4. Children whose parents/guardians provide informed consent.

Exclusion criteria

Exclusion Criteria:

  1. Children with chronic respiratory diseases.
  2. Children with congenital heart disease.
  3. Children with neuromuscular disorders.
  4. Children requiring mechanical ventilation
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    Side - Lying position Group

    Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the side-lying position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol.

    Behavioral: Nurse - Directed Side - Lying Positioning

  • Experimental
    Semi - Fowler's Position Group

    Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the semi-Fowler's position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol.

    Behavioral: Nurse - Directed Semi-fowler's positioning

  • No intervention
    Control Group

    Children aged 3-5 years diagnosed with pneumonia will receive routine nursing care according to the hospital's standard practice. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol.

Interventions

  • BehavioralNurse - Directed Side - Lying Positioning

    Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be placed in the side-lying position under nursing supervision, with attention to comfort, safety, and clinical tolerance. The selected side, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention.

  • BehavioralNurse - Directed Semi-fowler's positioning

    Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be positioned in the semi-Fowler's position, with the head and upper body elevated according to the study protocol. Nursing supervision will be provided to maintain the child's comfort and safety and to monitor clinical tolerance. The elevation angle, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention.

06

What researchers measure

Primary outcomes

  1. Change in Respiratory Rate

    Respiratory rate will be measured in breaths per minute and compared among the semi-Fowler, side-lying, and control groups.

    Time frame: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.

  2. Change in Respiratory Distress Severity

    Respiratory distress severity will be assessed using the Clinical Respiratory Score (CRS), which consists of six parameters: respiratory rate, auscultation, use of accessory muscles, mental status, room air oxygen saturation, and skin color. Each parameter is scored from 0 to 2, yielding a total score ranging from 0 to 12. Higher scores indicate greater respiratory distress. Change in respiratory distress severity will be compared among the semi-Fowler, side-lying, and control groups.

    Time frame: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.

  3. Change in Peripheral Oxygen Saturation (SpO₂)

    Peripheral oxygen saturation will be measured using a pulse oximeter and compared among the semi-Fowler, side-lying, and control groups.

    Time frame: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.

  4. Change in Heart Rate

    Heart rate will be measured in beats per minute and compared among the semi-Fowler, side-lying, and control groups.

    Time frame: At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. Data confidentiality will be maintained, and study findings will be reported in aggregate form without identifying individual participants.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07913191
Responsible party
Nidaa Hazem Mardan (MSc Candidate in Pediatric Nursing, University of Baghdad) — Principal investigator
First posted
Nov 3, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Nidaa H Mardan
Contact
nedaa.hazem2504m@conursing.uobaghdad.edu.iq
+9647807779284
Adraa H Shawq, Phd
Contact
Adraa H Shawq, Phd
principal investigator · University of Baghdad, College of Nursing

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion